Xylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats
Xylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats
Authorised
- Xylazine
Product identification
Medicine name:
Xylexx 20 mg/ml solution for injection for cattle, horses, dogs and cats
Xylexx 20 mg/ml Oplossing voor injectie
Xylexx 20 mg/ml Solution injectable
Xylexx 20 mg/ml Injektionslösung
Active substance:
- Xylazine
Target species:
-
Cat
-
Cattle
-
Dog
-
Horse
Route of administration:
-
Subcutaneous use
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Xylazine20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat and offal1day1 day
-
-
-
Intravenous use
-
Horse
-
Meat and offal1day1 day
-
-
Cattle
-
Meat and offal1day1 day
-
Milkno withdrawal periodzero hours
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Cardboard box containing 1 vial of 30 ml
- Cardboard box containing 5 vials of 30 ml
- Polystyrene box containing 24 vials of 30 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Alfasan Nederland B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V660898
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0366/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 28/11/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.